Methods in studying ECM degradation

被引:6
作者
Everts, Vincent [1 ,2 ]
Buttle, Dave J. [3 ]
机构
[1] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, NL-1081 BT Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, NL-1081 BT Amsterdam, Netherlands
[3] Univ Sheffield, Sch Med, Acad Unit Mol Med Rheumatol, Sheffield S10 2RX, S Yorkshire, England
关键词
extracellular matrix; collagen breakdown; proteoglycan breakdown; aggrecan; matrix metalloproteinases; ADAMTS;
D O I
10.1016/j.ymeth.2008.01.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Almost all tissues in our body contain specific cells associated with the tissue itself, and an extracellular matrix (ECM) that consists of a variety of proteins of which the bulk is formed by different types of collagens, glycoproteins and proteoglycans. The ECM plays a pivotal role in numerous processes not only related to the mechanical properties of a tissue, but also in modulating cellular activity. For a proper functioning of a tissue remodeling of the ECM is essential. Some connective tissues are characterized by a very rapid turnover (e.g. periodontal ligament) whereas others hardly show signs of turnover (e.g. cartilage). In all situations degradation of the ECM constituents occur. Under certain conditions, especially during a pathological situation, a high level of degradation may take place. In other situations matrix synthesis and deposition outstrips breakdown, leading to a fibrosis. In order to obtain information on the level of degradation of the different ECM components, various methods have been employed. A number of these methods will be discussed in this article. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:86 / 92
页数:7
相关论文
共 65 条
[1]   Osteoclasts generate cross-linked collagen N-telopeptides (NTx) but not free pyridinolines when cultured on human bone [J].
Apone, S ;
Lee, MY ;
Eyre, DR .
BONE, 1997, 21 (02) :129-136
[2]   A novel model system for characterization of phagosomal maturation, acidification, and intracellular collagen degradation in fibroblasts [J].
Arora, PD ;
Manolson, MF ;
Downey, GP ;
Sodek, J ;
McCulloch, CAG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :35432-35441
[3]   Proteoglycan deposition in pulmonary fibrosis [J].
Bensadoun, ES ;
Burke, AK ;
Hogg, JC ;
Roberts, CR .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (06) :1819-1828
[4]   Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage [J].
Billinghurst, RC ;
Dahlberg, L ;
Ionescu, M ;
Reiner, A ;
Bourne, R ;
Rorabeck, C ;
Mitchell, P ;
Hambor, J ;
Diekmann, O ;
Tschesche, H ;
Chen, J ;
VanWart, H ;
Poole, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1534-1545
[5]  
Brown CJ, 1996, J CLIN PATHOL-CL MOL, V49, pM331
[6]   Mechanisms involved in cartilage proteoglycan catabolism [J].
Caterson, B ;
Flannery, CR ;
Hughes, GE ;
Little, CB .
MATRIX BIOLOGY, 2000, 19 (04) :333-344
[7]   RAPID AND REPRODUCIBLE ASSAY FOR COLLAGENASE USING [ACETYLATED-1-C-14 COLLAGEN [J].
CAWSTON, TE ;
BARRETT, AJ .
ANALYTICAL BIOCHEMISTRY, 1979, 99 (02) :340-345
[8]   Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women:: The EPIDOS study [J].
Chapurlat, RD ;
Garnero, P ;
Bréart, G ;
Meunier, PJ ;
Delmas, PD .
BONE, 2000, 27 (02) :283-286
[9]   Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with Osteoarthritis and rheumatoid arthritis [J].
Charni, N ;
Juillet, F ;
Garnero, P .
ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1081-1090
[10]   Collagen type IIC-telopeptide fragments as an index of cartilage degradation [J].
Christgau, S ;
Garnero, P ;
Fledelius, C ;
Moniz, C ;
Ensig, M ;
Gineyts, E ;
Rosenquist, C ;
Qvist, P .
BONE, 2001, 29 (03) :209-215